Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.04 | 1.81 |
NAV | ₹13.68 | ₹99.30 |
Fund Started | 15 Aug 2023 | 31 Jul 2008 |
Fund Size | ₹1880.27 Cr | ₹4721.61 Cr |
Exit Load | Exit Load for units in excess of 5% of the investment,1% will be charged for redemption within 30 days. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 27.01% | 40.29% |
3 Year | - | 23.65% |
5 Year | - | 23.58% |
1 Year
3 Year
5 Year
Equity | 99.46% | 97.40% |
Cash | -0.14% | 2.60% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HCL Technologies Ltd. | 6.26% |
Ajanta Pharma Ltd. | 6.06% |
Alkem Laboratories Ltd. | 6.05% |
Coal India Ltd. | 5.73% |
HDFC Asset Management Company Ltd. | 5.29% |
Bajaj Auto Ltd. | 5.22% |
Torrent Pharmaceuticals Ltd. | 5.10% |
Bosch Ltd. | 4.99% |
Hero Motocorp Ltd. | 4.66% |
Colgate-Palmolive (India) Ltd. | 4.30% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 6.21% |
ICICI Bank Ltd. | 5.26% |
State Bank of India | 4.04% |
Infosys Ltd. | 3.90% |
Larsen & Toubro Ltd. | 2.88% |
Bharti Airtel Ltd. | 2.83% |
Dr. Reddy's Laboratories Ltd. | 2.73% |
ITC Ltd. | 2.54% |
CESC Ltd. | 2.29% |
Biocon Ltd. | 2.21% |
Name | Dhaval Patel | Satish Ramanathan |
Start Date | 08 Mar 2023 | 01 Oct 2024 |
Name
Start Date
Description | The Scheme is seeks to generate long term capital appreciation by investing in equity and equity related instruments across market capitalizations. | The scheme which aims to provide capital appreciation by investing primarily in equity and equity related securities of various market depending upon valuation discount or premium amongst Large / Mid & Small cap stocks, the fund will keep varying the weights to capture the value while keeping an optimum Risk / Return profile. |
Launch Date | 15 Aug 2023 | 31 Jul 2008 |
Description
Launch Date